SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | n/a |
Enterprise Value ($M) | n/a |
Book Value ($M) | 79,874.00 |
Book Value / Share | 35.60 |
Price / Book | n/a |
NCAV ($M) | -56,208.00 |
NCAV / Share | -25.05 |
Price / NCAV | n/a |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.56 |
Return on Assets (ROA) | 0.31 |
Return on Equity (ROE) | 0.92 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 0.67 |
Current Ratio | 0.86 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 113,943.00 |
Assets | 250,025.00 |
Liabilities | 170,151.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 176,954.00 |
Operating Income | 75,620.00 |
Net Income | 55,525.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 78,887.00 |
Cash from Investing | -24,918.00 |
Cash from Financing | -51,797.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | BlackRock Inc. | 6.50 | -8.05 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
148,909 | 841,917 | 17.69 | |
190,858 | 1,257,243 | 15.18 | |
158,843 | 963,081 | 16.49 | |
(click for more detail) |
Similar Companies | |
---|---|
ABBV – Abbvie Inc | ABT – Abbott Laboratories |
ADCT – Adc Therapeutics SA | AMRX – Amneal Pharmaceuticals Inc – Class A |
APN – Apeiron Capital Investment Corp – Class A |
Financial data and stock pages provided by
Fintel.io